Rituxim
Rituxim is Rituximab, a monoclonal antibody against CD20. It is indicated for non-Hodgkin lymphoma, chronic lymphocytic leukemia, and other CD20-positive disorders and works by depleting B cells through targeted immune-mediated mechanisms.
Features
| Product Name | Rituxim |
| Generic Name | Rituximab |
| Formulation | 1x1's |
| Available Pack Size | 100 mg, 500 mg |
| Available Strength |